gabapentin
NDC 50228-523, gabapentin, tablet, from ScieGen Pharmaceuticals, Inc..
- Product NDC
- 50228-523
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218491
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50228-523 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN300 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-523-05 | 50228052305 | 500 TABLET in 1 BOTTLE (50228-523-05) |
| 50228-523-30 | 50228052330 | 30 TABLET in 1 BOTTLE (50228-523-30) |
| 50228-523-90 | 50228052390 | 90 TABLET in 1 BOTTLE (50228-523-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3f2e3ac5-5233-fd57-e063-6294a90a849eNADAC price for package 50228052390
GET /v1/drugs/nadac/50228052390
Use it
Look up 50228-523 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-523 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-523. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.